Cancer patients who enroll in a clinical trial and have no health insurance, or are enrolled in Medicaid may not get the same benefits of successful trial treatments that other cancer patients do.
Over the course of his first six months as NCI director, Anthony Letai has contended with federal budget turbulence, a record-setting government shutdown, and concerns about the flow of over research dollars.
